Bioscience


Harvest One Executing on Brands and Distribution Strategy

March 27th, 2019 - Ryan Allway

The nature of the compelling stories in the cannabis industry has changed over the last few years. Remember when a late-stage ACMPR applicant was all the rage? Then it was production expansion and funded capacity. Now, all of that potential is turning to the reality of any market – who can sell product and generate […]

Halo Labs Announces Repricing of Convertible Debenture Units and An Increase in The Expected Size of The Offering

March 15th, 2019 - Ryan Allway

TORONTO Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTC: AGEEF, Germany: A9KN) announces that it has agreed to amend the terms of its previously announced “best efforts” offering (the “Offering”) of convertible debenture units (the “Convertible Debenture Units”) to lower the conversion price at which the convertible debentures are convertible into common shares of […]

MedMen Announces Completion of Sale of Two Properties to Cannabis REIT

March 14th, 2019 - Ryan Allway

LOS ANGELES MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) (FSE: A2JM6N) today announced that it has completed the sale of two properties to Treehouse Real Estate Investment Trust, Inc. (“Treehouse”) with gross proceeds of approximately $33.5 million and net proceeds of approximately $30.6 million after repayment of debt. This press release features […]

FluroTech Advances Cannabis Biomarker Technology

March 12th, 2019 - Ryan Allway

The cannabis industry is projected to exceed $146 billion by 2025, according to Grand View Research, driven by the legalization of adult-use and medical cannabis around the world. With the breakneck pace, the industry has faced a number of growing pains along the way. Product recalls, counterfeit products, mislabeled products, and supply chain issues have […]

NexTech Raises $1,464,600 From $0.50 Warrant Conversion

March 8th, 2019 - Ryan Allway

New York, New York and Toronto, Ontario–(Newsfile Corp. – March 8, 2019) – NexTech AR Solutions (OTC Pink: NEXCF) (CSE: NTAR) (FSE: N29) (the “Company” or “NexTech”), a technology and emerging commercial growth company focused on bringing augmented reality (“AR”) to the masses through its web-enabled AR platform for eCommerce, announced today that further to […]

Global Water Concerns Drive Clean Water Technology: Where to Get Your H2O Next

March 7th, 2019 - Ryan Allway

POINT ROBERTS Wash. and DELTA, British Columbia, March 07, 2019 (GLOBE NEWSWIRE) — Investorideas.com and its water portal http://www.water-stocks.com, one of the first global investor news source covering the sector, release a snapshot looking at water purification technologies as rising concerns regarding drinkable water become a global theme and anthem. When you see Anheuser-Busch, the […]

FSD Pharma’s Investments Provide Unique Diversification

March 5th, 2019 - Ryan Allway

The Canadian cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis last year. With the upcoming legalization of edibles this fall, the market could significantly expand its addressable market beyond consumers willing to smoke cannabis. These dynamics could help lift the value […]

TransCanna Announces the Completion of 420 Global

February 14th, 2019 - Ryan Allway

Transcanna Holdings Inc. (CSE:TCAN, XETR:TH8) (“TransCanna” or the “Company”) is pleased to announce that it has completed phase I of its proprietary software platform called “420 Global”. The state-of-the-art proprietary software is designed to create a Business Intelligence backend that integrates accounting, human resources, procurement, manufacturing and project management solutions. 420 Global will allow the Company to […]

Next Green Wave Signs MOU with Organic Medical Growth to Enter the Colombian Medical Cannabis Market

February 14th, 2019 - Ryan Allway

Next Green Wave to take a strategic investment in Organic Medical Growth as the company moves towards a proposed IPO in 2019 Vancouver, British Columbia–(Newsfile Corp. – February 14, 2019) – Next Green Wave Holdings Inc. (CSE: NGW) (OTCQB: NXGWF) (“Next Green Wave” or the “Company”), is pleased to announce that it has entered into […]

Future Farm Maine Extends 100-Acre Lease for CBD-Producing Hemp

February 14th, 2019 - Ryan Allway

Vancouver, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQB: FFRMF) is pleased to announce that it has entered into a new lease with Haymart, LLC to grow CBD-producing hemp on the same 100-acre parcel which the Company leased from Haymart […]

YIELD GROWTH Manufactures 6 New Proprietary Urban Juve Products

February 14th, 2019 - Ryan Allway

VANCOUVER, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF) (Frankfurt:YG3) is pleased to announce that it is launching 6 new products with its proprietary hemp root oil under the Urban Juve brand: Vitalize Face Mist, Balance Face Mist, Align Face Mist, Vitalize Daily Ritual Oil, Balance Daily Ritual Oil […]

Helix TCS Subsidiary, BioTrackTHC, Receives NCIA Excellence in Innovation Award

February 14th, 2019 - Ryan Allway

DENVER, Feb. 14, 2019 /PRNewswire/ — Helix TCS (OTCQB: HLIX) (the “Company”) subsidiary, BioTrackTHC, was presented with an award for Excellence in Innovation in the category of Business Strategy and Innovation by the National Cannabis Industry Association (“NCIA”), the largest and longest running non-profit association in the legal cannabis industry. The award, which was presented yesterday […]

FluroTech’s CompleTest™ Makes Cannabis Testing More Accessible

February 14th, 2019 - Ryan Allway

The market for cannabis testing is projected to be $300 million in Canada, $750 million in the United States, and $2.75 billion worldwide. Despite the market size and tremendous need, most cannabis testing solutions are both expensive and unreliable. Cultivators struggle to optimize yields and contain infestations, while consumers have faced recalls for both contamination […]

Yield Growth Expanding Product Lines & Distribution Footprint

February 11th, 2019 - Ryan Allway

There’s no doubt that the cannabis industry is poised for rapid growth over the coming quarters, but investors have many options in the space. While licensed producers and retailers tend to capture the headlines, investors may want to take a closer look at companies developing innovative products lines in high-growth segments, such as the beverage, […]

Supreme Cannabis Expands Domestic Distribution to Eight Provinces

February 7th, 2019 - Ryan Allway

Supreme Cannabis’ wholly owned subsidiary, 7ACRES, has agreed to supply cannabis to retailers in the provinces of New Brunswick and Saskatchewan. 7ACRES now joins an exclusive group of licensed producers with recreational distribution in eight or more provinces. TORONTO, Feb. 7, 2019 /PRNewswire/ – The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSX: […]

Next Green Wave Announces DTC Eligibility

February 7th, 2019 - Ryan Allway

Vancouver, British Columbia–(Newsfile Corp. – February 7, 2019) – Next Green Wave Holdings Inc. (CSE: NGW) (OTCQB: NXGWF) (“Next Green Wave” or the “Company“), a Canadian based California operating cannabis company established to provide premium products and brands to both medicinal and adult use consumers, confirms that its OTCQB listed common shares under the symbol […]

FSD Pharma Signs Collaboration and Profit-Sharing Agreement with Pharmastrip for Production and Delivery of Organic Medical Cannabis Infused in Oral Thin Film Strips

February 7th, 2019 - Ryan Allway

Canada NewsWire TORONTO, Feb. 7, 2019 TORONTO, Feb. 7, 2019 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company), a licensed producer under the Cannabis Act, announced today that it has completed a strategic investment of $1.5 million in Pharmastrip Corp. and signed a definitive collaboration and profit sharing […]

NexTech Achieves Milestone Revenue Generation for January 2019

February 7th, 2019 - Ryan Allway

VANCOUVER and TORONTO, Feb. 7, 2019 /PRNewswire/ – NexTech AR Solutions (the “Company” or “NexTech”) (CSE: NTAR) (OTC: NEXCF) (FSE:N29) announced today it has achieved milestone revenue generation for the month of January 2019. The Company reported revenue of $284,000 USD OR $375,000 CDN, its highest monthly result to date. The Company attributes the strong revenue generation to […]

Chemesis International Inc. Acquires Intellectual Property for High-Quality Cannabis Extraction

February 7th, 2019 - Ryan Allway

Chemesis acquires the IP and physical extraction equipment for a methodology that utilizes a low-temperature process to produce a high concentration cannabis oil that preserves all constituents and phytocannabinoids VANCOUVER, British Columbia, Feb. 07, 2019 (GLOBE NEWSWIRE) —  Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces it has acquired intellectual property (“IP”) […]

CannabisNewsAudio Announces Audio Press Release (APR) on Lexaria Bioscience Corp. Gaining Appeal in Cannabis Edibles with DehydraTECH

February 1st, 2019 - Ryan Allway

NEW YORK, Feb. 01, 2019 (GLOBE NEWSWIRE) — via CannabisNewsWire – CannabisNewsAudio announces the Audio Press Release (APR) titled “Outside Investment, New Technology Support Growing Cannabis Industry,” featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP). To hear the CannabisNewsAudio version, visit: http://cnw.fm/uXf6S To read the full editorial, visit: http://cnw.fm/H3q7r DehydraTECH transforms the situation by seriously reducing […]

Yield Growth lists on the U.S. OTCQB Venture Market under the Symbol “BOSQF”

February 1st, 2019 - Ryan Allway

VANCOUVER, British Columbia, Feb. 01, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS)(OTCQB:BOSQF) (Frankfurt:YG3) is pleased to announce that the OTCQB Venture Market has approved the listing of the company’s shares on the OTCQB market under the ticker symbol “BOSQF” and that trading will begin at market open on February 1, 2019.  The company […]

CFN Media Interviews David Hyde, President of 3 Sixty Secure, A Leading Cannabis Consulting Firm

January 31st, 2019 - Ryan Allway

Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis last year. While the country is home to the world’s most mature cannabis market, Health Canada regulations continue to evolve and licensed producers require guidance to ensure that they’re both compliant with […]

How Cannabinoids Could Replace Opioids

January 28th, 2019 - Ryan Allway

Chronic pain affects more than 100 million Americans at an annual cost of $600 billion, according to the Institute of Medicine. The National Institute of Drug Abuse estimates that roughly 21 to 29 percent of chronic pain patients misuse opioid drugs and 8 to 12 percent go on to develop an opioid addiction. More than […]

Aleafia Health Study Indicates 45% of Patients End Benzodiazepine Use Following Medical Cannabis Treatment

January 25th, 2019 - Ryan Allway

Authors Leveraged Aleafia’s 10 Million Point Medical Cannabis Dataset TORONTO, Jan. 25, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), announces today what it believes to be the first study reporting reduced benzodiazepine use among patients initiated and monitored on medical cannabis. Benzodiazepines, a class […]

Transcanna Provides Investors with Exposure to Ancillary Cannabis Businesses

January 25th, 2019 - Ryan Allway

The global cannabis industry is projected to reach more than $150 billion by 2025, according to Grand View Research, driven by legalization across a growing number of countries. While most investors are focused on cannabis cultivators and retailers, these companies still face legal and logistical challenges in many jurisdictions. Ancillary service providers may be better […]

Pascal Biosciences Commences Cannabinoid Testing of Human Volunteers and Patients

January 24th, 2019 - Ryan Allway

VANCOUVER, British Columbia, and SEATTLE, Jan. 24, 2019 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the testing of cannabinoids in human subjects for its immune stimulatory program in cancer. Furthermore, the Company has filed an international patent application to protect this work for […]

YIELD GROWTH Announces listing in Frankfurt (YG3) and Trading Symbol on OTC Markets (OTC:BOSQF)

January 24th, 2019 - Ryan Allway

VANCOUVER, British Columbia, Jan. 24, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS) (BOSQF) (Frankfurt:YG3) is pleased to announce that Yield Growth’s common shares have been listed on the Frankfurt Stock Exchange under the trading symbol “YG3”. Yield Growth is also now quoted on OTC Markets under the symbol “BOSQF”. The company’s common shares […]

NexTech Forms Joint Marketing Partnership with CGTrader, its Preferred Supplier of 3D Models

January 24th, 2019 - Ryan Allway

VANCOUVER and TORONTO , Jan. 24, 2019 /CNW/ – NexTech AR Solutions (the “Company” or “NexTech”) (CSE: NTAR) (NEXCF) (FSE:N29) is pleased to announce that it has begun working with CGTrader as NexTech’s joint marketing partner where both companies will promote a combined product and service offering that includes conversion of 2D product into 3D and […]

Creso Pharma Gears Up for Adult-Use Market with New Supply Agreement

January 23rd, 2019 - Ryan Allway

Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte analysts, driven by the legalization of adult-use cannabis in October of last year. While many licensed producers have been scaling up their production, the market continues to experience a shortfall in supply that has created an opportunity for investors […]

Producing Supreme Cannabis At Scale

January 22nd, 2019 - Ryan Allway

Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte analysts, driven by the legalization of recreational cannabis last year. While many licensed producers are ramping up capacity, investors may want to shift their focus to the handful of companies that are doubling down on product quality. These companies […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading